ReviewExperimental biology and medicine (Maywood, N.J.)2026

How can we balance risk and benefit of interleukin-18 armored T cell therapies?

Paulina Vicenova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.